An interventional study of dental implant with transepithelial abutments manufactured by Galimplant Dental System (Spain) in Edentulous; Alveolar Process, Atrophy, sponsored by University of Salamanca. Completed at 1 site in Spain. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2022-03-17.
Sponsored by University of Salamanca · Not applicable, Interventional, and Treatment
The sample was comprised by 10 patients in which 40 dental implants are placed in an atrophic maxilla. All the implants were connected to 4 types of transepithelial abutment: i.e: parallel anodized abutment(n=10); parallel mechanized abutmen(n=10)t, convergent anodized abutment(n=10); and convergent mechanized abutment (n=10) three months after insertion implants were extracted with the surrounding hard and soft tissues for the histological evaluation of the clinical performance.
828 studies on the registry are indexed under Atrophy; 122 are open to participants now.
This study's enrollment of 10 is below the median of 34 across 603 interventional studies indexed under Atrophy.
Browse Atrophy studies →University of Salamanca is the lead sponsor of 110 studies on the registry; 48 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Implants were immediately covered with this type of abutments after insertion. This is the most common procedure. It would be the gold standard
Device: dental implant with transepithelial abutments manufactured by Galimplant Dental System (Spain)
Implants were immediately covered with this kind of abutments after insertion. Only the surface treatment varies to the gold standard
Device: dental implant with transepithelial abutments manufactured by Galimplant Dental System (Spain)
Implants were immediately covered with this kind of abutments after insertion. Only the geometry of the emergence profile varies with regards to the gold standard
Device: dental implant with transepithelial abutments manufactured by Galimplant Dental System (Spain)
Implants were immediately covered with this kind of abutments after insertion. Both the surface treatment and the geometry vary with regards to the gold standard
Device: dental implant with transepithelial abutments manufactured by Galimplant Dental System (Spain)
Dental implants with transepithelial abutments with distinct morphology
Bone to implant contact
It is a Percentage estimation of native bone in direct contact to implant determined by histological assessments (optical microscopy)
Time frame: 3 months after healing
Peri-implant inflammation of the soft tissues
Histological assessments as ordinal variables of the grade of inflammatory infiltrate (none, minor, major)according to standard guidelines.
Time frame: 3 months after healing
Density of the peri-implant soft tissues
Histological assessments as ordinal variables of the density of the collagen fibers (low, medium, high) according to standard guidelines.
Time frame: 3 months after healing
Plan to share: No
No publications or documents are linked to this record.
This study is completed, as verified in Feb 2022. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University of Salamanca